Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New ET-1 inhibitors from Ciba-Geigy

Dec. 16, 1996

Toray reports peptides for toxic shock syndrome

Dec. 16, 1996

New antihypertensive agents from Banyu

Dec. 16, 1996

Nortran's antiarrhythmic agents receive patent protection

Dec. 13, 1996

Ivax generic cardiovascular drug approved in U.S.

Dec. 13, 1996

New ET antagonist in preclinical testing at Parke-Davis

Dec. 13, 1996

PLC Systems allowed to expand Heart Laser trials

Dec. 13, 1996

Antihypertensive peptides disclosed by Snow Brand

Dec. 13, 1996

Roussel Uclaf reports new quinoline derivatives

Dec. 13, 1996

Millennium/Lilly's gene-based assay for atherosclerosis

Dec. 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....